Repinex, ropinirole XL, ropinirole prolonged release, ropinirole 2mg, ropinirole 4mg, ropinirole 8mg, ropinirole, Parkinson’s disease, levodopa adjunct, monotherapy Parkinson’s disease, levodopa, branded generic, category C drug tariff ropinirole, Aspire Pharma, UK. Repinex XL is a ropinirole prolonged-release tablet available in the UK from Aspire Pharma as three strengths, 2, 4 and 8mg. Repinex XL can be used as an initial monotherapy or in combination with levodopa for the treatment of Parkinson’s disease. By prescribing Repinex XL the NHS could save 50% of their prescribing costs for ropinirole XL. Available in the UK from Aspire Pharma, Repinex XL is a once daily ropinirole treatment for Parkinson’s disease as a monotherapy or adjunct to levodopa.

Revision reference – Repinex XL_16_11/01/2019